Si-Bone Inc Total Assets
Si-Bone Inc total assets. Based on the latest financial reports, Si-Bone Inc (SIBN) holds total assets worth $248.76 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Si-Bone Inc market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Si-Bone Inc (2013–2025)
Total assets of Si-Bone Inc from 2013 to 2025. This chart illustrates how Si-Bone Inc's total assets have evolved over time, based on quarterly financial data. See Si-Bone Inc (SIBN) stock price for real-time trading data and today's change.
Si-Bone Inc - Asset Composition Analysis
Si-Bone Inc Total Assets Breakdown (December 2025)
Si-Bone Inc total assets breakdown as of December 2025. Si-Bone Inc's total assets of $248.76 Million consist of 90.6% current assets and 9.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 17.7% |
| Accounts Receivable | $29.91 Million | 12.5% |
| Inventory | $33.90 Million | 14.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how Si-Bone Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Si-Bone Inc working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Si-Bone Inc's current assets represent 90.6% of total assets in 2025, a decrease from 91.4% in 2013.
- Cash Position: Cash and equivalents constituted 17.7% of total assets in 2025, down from 47.3% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 14.2% of total assets.
Si-Bone Inc Competitors by Total Assets
Key competitors of Si-Bone Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Si-Bone Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 9.15 | 8.38 | 12.75 |
| Quick Ratio | 7.55 | 7.00 | 12.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $195.87 Million | $182.70 Million | $171.08 Million |
Si-Bone Inc - Advanced Valuation Insights
This section examines the relationship between Si-Bone Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.50 |
| Latest Market Cap to Assets Ratio | 3.45 |
| Asset Growth Rate (YoY) | 3.5% |
| Total Assets | $238.56 Million |
| Market Capitalization | $823.77 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Si-Bone Inc's assets at a significant premium (3.45x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Si-Bone Inc's assets grew by 3.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Si-Bone Inc (2013–2025)
The table below shows the annual total assets of Si-Bone Inc from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $238.56 Million | +3.52% |
| 2024-12-31 | $230.44 Million | +0.01% |
| 2023-12-31 | $230.43 Million | +46.25% |
| 2022-12-31 | $157.55 Million | -17.30% |
| 2021-12-31 | $190.51 Million | -14.63% |
| 2020-12-31 | $223.14 Million | +90.70% |
| 2019-12-31 | $117.01 Million | -15.53% |
| 2018-12-31 | $138.52 Million | +286.56% |
| 2017-12-31 | $35.83 Million | -9.13% |
| 2016-12-31 | $39.44 Million | +9.38% |
| 2015-12-31 | $36.05 Million | +24.39% |
| 2014-12-31 | $28.98 Million | +60.90% |
| 2013-12-31 | $18.01 Million | -- |
About Si-Bone Inc
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium … Read more